Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to -$21.7 million.

  • Mainz Biomed N.V's Net Income towards Common Stockholders rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.82% up from last year.
  • As of FY2024, Mainz Biomed N.V's Net Income towards Common Stockholders stood at -$21.7 million, which was up 17.82% from -$26.3 million recorded in FY2023.
  • Mainz Biomed N.V's Net Income towards Common Stockholders' 5-year high stood at -$586,895 during FY2020, with a 5-year trough of -$26.4 million in FY2022.
  • Over the past 3 years, Mainz Biomed N.V's median Net Income towards Common Stockholders value was -$26.3 million (recorded in 2023), while the average stood at -$24.8 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 38.68% in 2020, then tumbled by 1,891.86% in 2021.
  • Yearly analysis of 5 years shows Mainz Biomed N.V's Net Income towards Common Stockholders stood at -$586,895 in 2020, then tumbled by 1,891.86% to -$11.7 million in 2021, then tumbled by 125.72% to -$26.4 million in 2022, then increased by 0.16% to -$26.3 million in 2023, then increased by 17.82% to -$21.7 million in 2024.